Skip to main content
Clinical Trials/NCT01065311
NCT01065311
Completed
Phase 2

Mindfulness-based Cognitive Therapy for Chronic Depression

Johannes Michalak1 site in 1 country106 target enrollmentOctober 2010

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Chronic Major Depression
Sponsor
Johannes Michalak
Enrollment
106
Locations
1
Primary Endpoint
Hamilton Rating Scale for Depression
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The propose of the study is to investigate the efficacy of Mindfulness-based Cognitive Therapy (MBCT, Segal, Williams, & Teasdale, 2002) for patients suffering from Chronic Major Depression. The efficacy of MBCT will be compared with the Cognitive Behavioral Analysis System of Psychotherapy (McCullough, 2003), a treatment approach, which has proven it's efficacy yet, and with a treatment-as-usual condition (standard psychiatric outpatient care).

Detailed Description

Cognitive Behavioral Analysis System of Psychotherapy (CBASP) is a treatment approach specifically developed for the treatment of chronic depression. CBASP aims to change dysfunctional interpersonal patterns. Mindfulness-based Cognitive Therapy (MBCT) has recently been proposed as a further treatment option for chronic depression. MBCT trains patients to step out of negative ruminative states of mind. There are no direct comparisons of the psychological treatment options for chronic depression.

Registry
clinicaltrials.gov
Start Date
October 2010
End Date
May 2013
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Johannes Michalak
Responsible Party
Sponsor Investigator
Principal Investigator

Johannes Michalak

Prof. Dr. phil.

Ruhr University of Bochum

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnoses of Major Depression, single episode, chronic or
  • Major Depression, recurrent, chronic
  • Hamilton Rating Scale for Depression score \> 14
  • Beck Depression Inventory II score \> 14

Exclusion Criteria

  • History of Schizophrenia or Schizoaffective Disorder
  • Current Substance Dependence or Eating Disorder
  • Mental Disorder Due to General Medical Condition
  • Borderline Personality Disorder

Outcomes

Primary Outcomes

Hamilton Rating Scale for Depression

Time Frame: Change from Baseline in HAM-D at 8 weeks

Secondary Outcomes

  • Beck Depression Inventory II(Change from Baseline in BDI-II at 6 months)
  • Social Adaption Self-evaluation Scale(Change from Baseline in SASS at 6 months)
  • Short Form (36) Health Survey(Change from Baseline in SF-36 at 6 months)
  • Global Assessment of Functioning Scale(Change from Baseline in GAF at 6 months)
  • Response Styles Questionnaire(Change from Baseline in RSQ at 6 months)

Study Sites (1)

Loading locations...

Similar Trials